Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
48-66
Author(s):
Joshua K. Ko and Kathy K. Auyeung
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
814-822
Author(s):
P. Tassone, P. Neri, R. Burger, M. T. Di Martino, E. Leone, N. Amodio, M. Caraglia and P. Tagliaferri
The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3335-3355
Author(s):
Laurens P. Kil, Saravanan Yuvaraj, Anton W. Langerak and Rudi W. Hendriks
Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1025-1029
Author(s):
A. Sacco, I. M. Ghobrial and A. M. Roccaro
Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3753-3771
Author(s):
Petr Heneberg
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
254-284
Author(s):
G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar
Epidemiology and Management of Infectious Complications in Contemporary Management of Chronic Leukemias
Journal:
Infectious Disorders - Drug Targets
Volume:
11
Page:
3-10
Author(s):
Jo-Anne H. Young
Systems Biology of Apoptosis and Survival: Implications for Drug Development
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
190-203
Author(s):
Salvatore Pezzino, Sabrina Paratore and Sebastiano Cavallaro
Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
716-727
Author(s):
R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer
Monoclonal Antibody Therapy in Haematological Malignancies
Journal:
Current Clinical Pharmacology
Volume:
5
Page:
148-159
Author(s):
Martine E.D. Chamuleau, Arjan A. van de Loosdrecht and Peter C. Huijgens